Arizona Oncology

Recent papers from Arizona Oncology

1. Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancerJCI Insight · 2026
2. Lipid nanoparticle co-delivery of siRNA silencing P-glycoprotein overcomes Camptothecin resistance in an acute lymphoblastic leukemia modelActa Pharmaceutica Sinica B · 2026
3. Contralateral Prophylactic Mastectomy at the Time of Therapeutic Mastectomy for Local Recurrence of Breast Cancer: Influence of Genetic Testing and Other FactorsJournal of Surgical Oncology · 2026
4. A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular ImagingAmerican Journal of Roentgenology · 2026
5. A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM) and paricalcitol as neoadjuvant therapy in pancreatic cancerThe Oncologist · 2026
6. 1889-P: Acute Proteomic Inflammatory Signatures from Infusion Cannulas Associated with CSII Therapy at Insulin Infusion SitesDiabetes · 2026
7. p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid LeukemiaCancer Research Communications · 2026
8. Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapyInternational Journal of Gynecological Cancer · 2026
9. Integration of PSMA PET into the New Recommendations from Prostate Cancer Working Group 4 for Prostate Cancer TrialsJournal of Nuclear Medicine Technology · 2026
10. Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.Journal of Clinical Oncology · 2026
11. Attenuation of long-term survival benefit of biological therapy in metastatic colorectal cancer (mCRC): Real-world data validation and molecular characterization.Journal of Clinical Oncology · 2026
12. ARTEMIDE-Biliary02: A phase 3, randomized, global study of rilvegostomig or durvalumab with chemotherapy as first-line (1L) treatment for advanced biliary tract cancer (BTC).Journal of Clinical Oncology · 2026
13. Post-hoc efficacy and biomarker analysis of elraglusib plus gemcitabine/nab-paclitaxel versus chemotherapy alone in metastatic pancreatic ductal adenocarcinoma.Journal of Clinical Oncology · 2026
14. Survival outcomes of human epidermal growth factor receptor 2 (HER2)–amplified and HER2-mutated left-sided colorectal cancer (CRC) patients treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs).Journal of Clinical Oncology · 2026
15. Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet)Frontiers in Immunology · 2026
16. Persistent CAR-T signal in delayed immune effector cell-associated enterocolitis following axicabtagene ciloleucelLeukemia & lymphoma/Leukemia and lymphoma · 2026
17. Artificial recombinant high-density protein nanocarriers for precision drug deliveryChemical Science · 2026
18. Guiding pluripotent stem cell therapies past the immune systemStem Cells Translational Medicine · 2026
19. Boosting immunogenic tumour cell death via nanotherapeutic targeting of the Stanniocalcin 1 phagocytosis checkpoint for enhanced cancer immunotherapyNature Communications · 2026
20. Cutaneous fistula of the breast: A complication of cosmetic autologous fat transferRadiology Case Reports · 2026